AVID BIOSERVICES INC. - COMMON STOCK

Avid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by GHO and Ampersand

30 ديسمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Avid Bioservices Recommends Stockholders Vote FOR Value Maximizing Transaction

18 ديسمبر 2024 15:35:00 بحسب Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024

10 ديسمبر 2024 15:05:23 بحسب Nasdaq GlobeNewswire

Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction

06 نوفمبر 2024 17:04:07 بحسب Nasdaq GlobeNewswire

Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference

12 سبتمبر 2024 15:05:27 بحسب Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024

09 سبتمبر 2024 15:05:31 بحسب Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024

03 سبتمبر 2024 15:05:20 بحسب Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024

02 يوليو 2024 15:05:04 بحسب Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024

01 يوليو 2024 06:00:21 بحسب Nasdaq GlobeNewswire

Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance

23 مايو 2024 07:05:46 بحسب Nasdaq GlobeNewswire

Avid Bioservices to Participate at Upcoming Investor Conferences

07 مايو 2024 15:05:11 بحسب Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024

24 أبريل 2024 16:25:33 بحسب Nasdaq GlobeNewswire

Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q

20 مارس 2024 06:00:10 بحسب Nasdaq GlobeNewswire

Avid Bioservices Announces Pricing of Private Placement of Convertible Notes

06 مارس 2024 22:58:48 بحسب Nasdaq GlobeNewswire

Avid Bioservices Announces Proposed Private Placement of Convertible Notes

06 مارس 2024 15:32:07 بحسب Nasdaq GlobeNewswire

Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024

06 مارس 2024 15:31:28 بحسب Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023

07 ديسمبر 2023 15:05:38 بحسب Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023

30 نوفمبر 2023 15:05:57 بحسب Nasdaq GlobeNewswire

Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs

08 نوفمبر 2023 07:05:03 بحسب Nasdaq GlobeNewswire

Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing Facility

17 أكتوبر 2023 07:05:09 بحسب Nasdaq GlobeNewswire